With market for H deteriorating rapidly comvined with the epic failures of their drug pipeline and acquisitions....it's not going to take much ..... 83 billion in debt....holders should be sweating profusely...
m
FDA Approves First Interchangeable Humira Biosimilar -- Market Talk 12:23 pm ET October 18, 2021 (Dow Jones) Print 1223 ET - The FDA gives the green light to Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's blockbuster Humira, the world's biggest-selling drug, which is used to treat diseases from rheumatoid arthritis to gut disorders. The FDA originally approved Cyltezo in 2017 for multiple chronic inflammatory diseases, and the new designation makes it interchangeable across the indications, meaning it can be substituted without the prescriber having to change the prescription. AbbVie has successfully used patent litigation to fend off the entry of Humira biosimilars. Boehringer Ingelheim struck a deal with AbbVie in 2019 that let the German company launch its Humira rival in July 2023
X
Successful people don't become that way overnight. What most people see at a glance wealth, a great career, purpose is the result of hard work and hustle over time. I pray that anyone reads this will be successful in life
m
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU) Fri, October 15, 2021, 7:35 AM
S
ISRG reports ah with ABT in the morning. Maybe we'll get a jolt. My biotechs have been underperforming terribly lately.
X
way oversold, forward PE 7.82: strong buy
M
Ex divi digested. Yummy 😋
L
look at some of these trades on Nasdaq after hours
STRONG BUY HERE AT THESE LEVELS , collect you’re dividends
S
Being manipulated once again!
m
Health Canada Approves the Use of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis Thu, October 7, 2021, 12:22 PM
M
abbv is down cause of EX DIV
m
FDA Approves QULIPTA™ (atogepant), the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine Tue, September 28, 2021, 6:42 PM
J
Of course, I'm going to continue buying while the price is down. Warren Buffet always says when others are greedy be fearful and when others are fearful be greedy!!! Well on Warren Buffet's advice I did my research and I will be very GREEDY and buy as much ABBV as I can afford!
J
Guys you do know that this is all smoke and mirrors from shorts trying to buy in cheaper
J
watch ABBV be over 116.00 next week Keep pushing your short b.s and watch what happens
k
Do you have money in the money market? Put it here, collect about five times as much and ignore the fluctuations
Great company, great dividend, long term winner.
12:23 pm ET October 18, 2021 (Dow Jones) Print
1223 ET - The FDA gives the green light to Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's blockbuster Humira, the world's biggest-selling drug, which is used to treat diseases from rheumatoid arthritis to gut disorders. The FDA originally approved Cyltezo in 2017 for multiple chronic inflammatory diseases, and the new designation makes it interchangeable across the indications, meaning it can be substituted without the prescriber having to change the prescription. AbbVie has successfully used patent litigation to fend off the entry of Humira biosimilars. Boehringer Ingelheim struck a deal with AbbVie in 2019 that let the German company launch its Humira rival in July 2023
Fri, October 15, 2021, 7:35 AM
After Hours Time (ET) After Hours Price After Hours Share Volume
16:06:16 $108.46 1
16:06:11 $108.52 3
16:05:34 $108.57 9,791
16:04:58 $108.51 2
16:04:57 $108.51 25
16:04:52 $108.435 1
16:04:52 $108.52 1
16:04:32 $108.57 9,350
16:03:49 $108.48 5
16:03:21 $108.43 1
16:03:19 $108.5 25
16:02:35 $108.52 100
16:02:27 $108.52 10
16:02:27 $108.57 306
16:02:27 $108.57 942
16:02:27 $108.57 162
16:02:26 $108.57 20,728
16:02:26 $108.57 4,487
16:02:26 $108.57 1,580
16:02:26 $108.57 2,187
Thu, October 7, 2021, 12:22 PM
Tue, September 28, 2021, 6:42 PM
Warren Buffet always says when others are greedy be fearful and when others are fearful be greedy!!!
Well on Warren Buffet's advice I did my research and I will be very GREEDY and buy as much ABBV as I can afford!
you do know that this is all smoke and mirrors from shorts trying to buy in cheaper
Keep pushing your short b.s and watch what happens